Farcast is a global leader in human tumor histoculture science and offers a unique platform to evaluate tumoricidal and immune response to drugs in live ex-vivo human cancer tissues. Farcast offers a wide array of assays to study the impact of drugs and predict the likely response in human tumors. More than 25 Oncology companies have benefited from working with us in progressing the development of their drug candidates to and through clinic.
Our NABL (ISO 15189) accredited lab is housed in a 28,000 sq feet facility and a wide network of IRB accredited cancer centers ensures access to fresh tumor samples from informed and consented patients.